Published August 12, 2012. 

Amit Lahoti*, Christine Yu, Preneet Cheema Brar, Austin Dalgo, Evgenia Gourgari, Rebecca Harris, Manmohan K. Kamboj, Seth Marks, Radha Nandagopal, Laura Page, Vandana Raman, Danielle G. Reynolds, Kyriakie Sarafoglou, Carrie Terrell, and Takara L. Stanley, on behalf of the Pediatric Endocrine Society Drug & Therapeutics Committee.

Abstract: Suppression of menstruation and/or ovarian function in adolescent girls may be desired for a variety of reasons. Numerous medical options exist. The choice of the appropriate modality for an individual patient depends on several factors based on differences in the efficacy of achieving menstrual suppression as well as in their side effect profiles. Adolescence is also a period of bone mass accrual in girls, and several of these modalities may negatively influence peak bone mass. This review focuses on the efficacy of achieving menstrual suppression and the effect on bone health of the various options through an overview of the current literature and also highlights areas in need of further research.